AA
ACIU icon

ALPS Advisors’s AC Immune ACIU Stock Holding History

ALPS Advisors’s Portfolio ACIU Stock Details ACIU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-76,630
Closed -$290K – 991
2024
Q3 		$290K Sell
76,630
-746
-1% -$2.6K ﹤0.01% 963
2024
Q2 		$309K Buy
+77,376
New +$256K ﹤0.01% 832
2021
Q4 		– Sell
-89,040
Closed -$597K – 889
2021
Q3 		$597K Sell
89,040
-6,655
-7% -$47.6K 0.01% 480
2021
Q2 		$759K Sell
95,695
-34,310
-26% -$237K 0.01% 447
2021
Q1 		$989K Buy
130,005
+121
+0.1% +$864 0.01% 399
2020
Q4 		$672K Buy
+129,884
New +$663K 0.01% 440
2019
Q4 		– Sell
-134,736
Closed -$667K – 815
2019
Q3 		$667K Sell
134,736
-6,636
-5% -$35.6K 0.01% 421
2019
Q2 		$785K Sell
141,372
-21,335
-13% -$109K 0.01% 381
2019
Q1 		$822K Buy
162,707
+7,029
+5% +$44.7K 0.01% 373
2018
Q4 		$1.47M Buy
+155,678
New +$1.47M 0.01% 249
2017
Q2 		– Sell
-47,658
Closed -$485K – 768
2017
Q1 		$485K Sell
47,658
-5,577
-10% -$68.4K ﹤0.01% 496
2016
Q4 		$691K Buy
+53,235
New +$737K 0.01% 245

Other funds holding ACIU

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

ALPS Advisors's ACIU Position: Q4 2024 in Review

ALPS Advisors sold out of AC Immune (ACIU) in Q4 2024, closing a stake of 76,630 shares — an estimated $290K sold.

ALPS Advisors first reported a position in ACIU in Q4 2016 and held it in 12 quarters. The position peaked at $1.47M in Q4 2018. 45 funds tracked by Wall St. Rank hold ACIU as of Q4 2024.

  • ALPS Advisors reported no remaining AC Immune position as of Q4 2024 after selling out during the quarter.
  • ALPS Advisors sold 76,630 AC Immune shares in Q4 2024, an estimated $290K.
  • ALPS Advisors first reported a position in AC Immune in Q4 2016 and held it in 12 quarters.
  • ALPS Advisors's AC Immune position peaked at $1.47M in Q4 2018.
  • 45 funds tracked by Wall St. Rank held AC Immune as of Q4 2024.

Based on ALPS Advisors's 13F filing for Q4 2024, filed 13 Feb 2025.